EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q2 2025 Earnings Call Transcript August 6, 2025
EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, expectations were $-0.67.
Operator: Good morning. My name is Antoine, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Second Quarter 2025 Financial Results and Recent Corporate Developments Conference Call. [Operator Instructions] Please be advised...
